Ignite Creation Date:
2024-05-06 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 12:46 PM
Study NCT ID:
NCT03531931
Status:
UNKNOWN
Last Update Posted:
2018-05-22
First Post:
2018-05-09
Brief Title:
Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer a Single-arm Exploratory Clinical Pilot Trial
Sponsor:
Organization:
The First Affiliated Hospital of Xiamen University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
20
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Only |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 48427 |
Who Masked List: